Health Ministry ignores e-cigarette use among teenagers

Survey of pupils shows 30% smoke nargilas.

December 11, 2016 17:47
2 minute read.

hookah. (photo credit: REUTERS)


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Although the US surgeon-general has taken electronic cigarettes (e-cigs) very seriously and called them a “growing threat to the health of young people,” the Health Ministry in Jerusalem has not.

In fact, it did not even include the use of e-cigs in its MABAT survey of the health practices of 6,274 junior and senior high school pupils released last week, but only the smoking of cigarettes and nargilas (hookahs, or water pipes).

In that survey, 30% of pupils in grades seven through 12 reported that they smoke nargilas, a figure that was higher than their self-reported use of cigarettes. But there was not a single question about the use of e-cigs, thus the ministry cannot know how widespread their use is here.

When asked to comment on the surgeon general’s warning, the ministry said: “E-cigs have not succeeded in penetrating the Israeli market significantly, especially not in teenagers. We do not have intentions of advancing regulation on them at this stage.”

But it did not explain how it knew teens don’t use e-cigs if the subject was omitted from the MABAT survey.

E-cigs, which contain concentrates of nicotine or other compounds that can be carcinogenic when heated, do not produce regular smoke. Consisting of a battery, a device that heats the chemical and a container to store it, an electronic cigarette vaporizes the powder or liquid into synthetic smoke, or vapor. There has been at least one case in Israel in which a toddler died after consuming the active ingredients in his parents’ e-cigs.

Although initially e-cigs became popular in the US as a way to help users to quit or to reduce cigarette smoking, there is no proof that they are effective for that or even that they are safe. As a result, they cannot be sold in pharmacies, by Health Ministry order.

Over the weekend, Surgeon General Dr. Vivek Murthy – the top federal medical authority in the US – called for efforts to minimize the use of e-cigs among teenagers. He maintained that the use of such products among American teens has risen dramatically – nine-fold in the last four years – and that their use today is more common than ordinary cigarettes made from tobacco.

According to figures from the surgeon-general’s office, almost two out of five US high school pupils have tried e-cigs at least once.
Murthy said that the chemicals in e-cigs can damage young brains at a stage when they are still developing, and that the vapors can create a dangerous aerosol that affects people surrounding the e-cig smoker. Other public health experts have opposed e-cigs because addiction to the nicotine in them can induce young people to switch to tobacco-filled, burnable cigarettes.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

May 27, 2019
Teva agreed to pay Oklahoma $85m to settle opioid claims